What is Embecta Corp. (EMBC) stock price today?

Embecta Corp. (EMBC) is currently trading at $5.75, down 2.71% today.

What is EMBC P/E ratio?

Embecta Corp.'s P/E ratio is 3.97. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is EMBC return on equity (ROE)?

Embecta Corp.'s return on equity (ROE) is -13.98%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is Embecta Corp.'s market cap?

Embecta Corp. has a market capitalization of $341.13M.

NASDAQ · Drug Manufacturers - Specialty & Generic

Embecta Corp. (EMBC) Stock

$5.75 -2.71% NASDAQ: EMBC Healthcare

Valuation

Metric	Value
Price	$5.75
Market Cap	$341.13M
P/E Ratio	3.97
P/B Ratio	-0.56
P/S Ratio	0.34
EPS (TTM)	$1.62
52-Week High	$14.91
52-Week Low	$2.77
Dividend Yield	0.68%

Financials & Margins

Metric	Value
ROE	-13.98%
ROA	6.92%
ROCE	29.93%
Gross Margin	30.46%
Operating Margin	30.46%
Net Margin	8.59%
Debt/Equity	-2.45
Current Ratio	2.41

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$1.2B	$1.1B	$1.1B	$1.1B	$1.1B
Operating Profit	$492.0M	$378.0M	$230.0M	$174.0M	$329.0M
Net Profit	$415.0M	$224.0M	$70.0M	$78.0M	$95.0M
EPS	$7.31	$3.89	$1.22	$1.34	$1.62
Op Margin	42.2%	33.5%	20.5%	15.5%	30.5%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$788.0M	$1.1B	$1.2B	$1.3B	$1.1B
Total Liabilities	$194.0M	$2.0B	$2.0B	$2.0B	$1.7B
Cash	$0	$331.0M	$326.0M	$268.0M	$226.0M
Borrowings	$4.0M	$1.6B	$1.6B	$1.6B	$1.4B

Latest News

Embecta (EMBC) Stock Fair Value Moves Lower As Analysts Reset Medtech Expectations Simply Wall St. · Jul 15, 2026 embecta appoints Nimish Muzumdar as SVP and President, North America GlobeNewswire · Jun 16, 2026 Marvell Technology and Flex Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 PR Newswire · Jun 5, 2026 embecta to Participate in Investor Events GlobeNewswire · Jun 1, 2026 Embecta (EMBC) Hit With A Sharp Target Cut As Medtech Sentiment Weakens Insider Monkey · May 24, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$456.0M	$412.0M	$68.0M	$36.0M	$192.0M
Investing Cash Flow	$-78.0M	$-48.0M	$-53.0M	$-32.0M	$-19.0M
Financing Cash Flow	$-417.0M	$-1.5B	$-4.0M	$-3.0M	$-6.0M
Net Cash Flow	$0	$331.0M	$-4.0M	$-52.0M	$-46.0M
Free Cash Flow	$417.0M	$388.0M	$41.0M	$20.0M	$182.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.80
EV / EBITDA	5.98
FCF Yield	46.94%
Quick Ratio	1.68
Interest Coverage	2.62
Return 1Y	-68.86%
Return 3Y	-83.58%
Return 5Y	—

Ownership

Insiders Held1.74%

Institutions Held100.57%

Institutions Float Held102.35%

Institutional Holder	Shares	Report Date
Blackrock Inc.	9,167,212	2026-03-31
Yacktman Asset Management Lp	3,671,877	2026-03-31
River Road Asset Management, LLC	3,449,502	2026-03-31
American Century Companies Inc	3,439,512	2026-03-31
Vanguard Capital Management LLC	2,563,951	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
AQSTAquestive Therapeutics, Inc.	$4.76	+3.03%	-7.11	$597.22M	0.00%
CDNACareDx, Inc.	$62.21	-1.32%	30.21	$3.22B	0.00%
EBSEmergent BioSolutions Inc.	$6.81	-3.68%	-1.84	$351.37M	0.00%
EVHEvolent Health, Inc	$3.96	-4.35%	-0.77	$445.43M	0.00%
MRVIMaravai LifeSciences Holdings, Inc.	$7.21	-2.96%	-14.75	$1.99B	0.00%

About Embecta Corp.

Embecta Corp. is led by CEO Devdatt Kurdikar, employs 2,000 people, headquartered in US, publicly traded since 2022.

Embecta Corp. (EMBC) stock trades at $5.75 with a market capitalization of $341.13M. The stock is valued at a price-to-earnings (P/E) ratio of 3.97, price-to-book of -0.56, price-to-sales of 0.34. Over the past 52 weeks the stock has ranged between $2.77 and $14.91, and currently trades 61.4% below its 52-week high. It pays a dividend yielding 0.68%.

On profitability, Embecta Corp. generates a return on equity (ROE) of -13.98%, return on capital employed of 29.93%, an operating margin of 30.46%, a net profit margin of 8.59%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1169.93 -1.58% JNJ Johnson & Johnson $256.48 -0.76% ABBV AbbVie Inc. $272.42 +0.39% MRK Merck & Company, Inc. Common Stock (new) $142.40 -0.28% UNH UnitedHealth Group Incorporated Common Stock (DE) $370.95 -1.34% NVS Novartis AG $143.11 -0.12% AZN AstraZeneca PLC $158.78 -0.84% TMO Thermo Fisher Scientific Inc $651.98 -1.52% AMGN Amgen Inc. $407.44 -1.37% GILD Gilead Sciences, Inc. $147.10 +0.17% ABT Abbott Laboratories $98.49 -0.24% NVO Novo Nordisk A/S $38.18 -0.21%

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides